搜索筛选:
搜索耗时0.0887秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
发布年度:
Research progress in the use of combinations of platinum-based chemotherapy and epidermal growth fac
[期刊论文] 作者：Chi Pan,Suzhan Zhang,Jianjin H,
来源：中德临床肿瘤学杂志：英文版 年份：2013
在过去的十年，表皮的生长因素受体酷氨酸 kinase 禁止者(EGFR-TKIs ) 的来临戏剧性地为治疗肺癌症影响了治疗学的策略，但是与肿瘤前进和药抵抗，病人们将最终开发减少的敏感到 EG...
[期刊论文] 作者：Chi Pan,Suzhan Zhang,Jianjin Huang,,
来源：The Chinese-German Journal of Clinical Oncology 年份：2013
In the past decade,the advent of the epidermal growth factor receptor-tyrosine kinase inhibitors(EGFR-TKIs)has dramatically influenced the therapeutic strategie...
[期刊论文] 作者：Jianzhen Shan,Yanyan Xuan,Qi Zhang,Chunpeng Zhu,Zhen Liu,Suzhan Zhang,
来源：蛋白质与细胞 年份：2016
...
[期刊论文] 作者：Caixia Dong,Yuwei Ding,Shanshan Weng,Guichao Li,Yanqing Huang,Hanguang Hu,Zhen Zhang,Suzhan Zhang,Ying,
来源：中国癌症研究:英文版 年份：2021
Colorectal cancer(CRC) is one of the major cancers threatening life and health of Chinese residents. According to the latest data released by the National Cancer Center in2015(1), there were 387,000 new cases and 187,100 deaths of CRC in Ch......
[期刊论文] 作者：,Yi Wang,Weiqi Sheng,Xinxiang Li,Aiping Zhou,Zhen Zhang,Guichao Li,Sanjun Cai,Ruihua Xu,Jin Li,Suzhan Zhang,
来源：中国癌症研究（英文版） 年份：2019
According to the latest data from cancer registration center,there are estimated to be 3,929,000 individuals newly diagnosed with cancer and 2,338,000 deaths fr...
[期刊论文] 作者：,Yi Wang,Weiqi Sheng,Xinxiang Li,Aiping Zhou,Zhen Zhang,Guichao Li,Sanjun Cai,Ruihua Xu,Jin Li,Suzhan Zhang,
来源：中国癌症研究（英文版） 年份：2020
According to the latest data released by the National Cancer Center, colorectal cancer (CRC) had the third highest incidence and the fifth highest mortality of...
Efficacy and safety of chemotherapy combined with bevacizumab in Chinese patients with metastatic co
[期刊论文] 作者：Tang,Wei Wang,Zuoxing Niu,Feng Bi,Liangjun Zhu,Zengqing Guo,Jin Yan,Bing Hu,Min Tao,Shujun Yang,Suzhan Zhang,
来源：中国癌症研究:英文版 年份：2021
Objective:Bevacizumab has an important and evolving role in improving outcomes in patients with metastatic colorectal cancer(mCRC)worldwide and was approved in China in 2010.However,there are limited real-world data on the efficacy and safe......
相关搜索：
